Loading clinical trials...
Loading clinical trials...
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus 50/500 µg/Inhalation: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Conditions
Interventions
Salmeterol/fluticasone Easyhaler
Salmeterol/fluticasone Easyhaler with charcoal
+2 more
Locations
1
Finland
Orion Pharma pharmacology Unit
Espoo, Finland
Start Date
July 1, 2016
Primary Completion Date
November 1, 2016
Completion Date
November 1, 2016
Last Updated
March 3, 2017
NCT07219173
NCT02327897
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Orion Corporation, Orion Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions